📰 C Diff News
Page 3 - C Diff News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from C Diff. Real-time updates on events, politics, business and more.
October 10, 2023
Social vulnerability index, race, and poverty were associated with increased rates of CDI, calling attention to population-level health disparities.
October 7, 2023
A new study conducted by researchers at The University of Texas MD Anderson Cancer Center suggests that enhanced infection prevention and control (IPC) measures implemented to address the COVID-19 pandemic contributed to a significant decrease in many healthcare-associated infections (HAIs) and a reduction in respiratory viral infections (RVIs).
September 29, 2023
More than 90% of patients with CDI treated with WMT achieved clinical cure, while only 3.8% of WMTs resulted in adverse events.
September 28, 2023
Results from the systematic review and meta-analysis showed FMT restored the normal microbiome, reduced the risk of gastrointestinal infections, and did not lead to increased adverse events in patients with HIV.
September 27, 2023
Findings revealed more than 5,000 excess deaths from CDI and 35.6% excess risk compared to the expected number of disease deaths calculated using data from the National Vital Statistics System.
September 19, 2023
Hospital staff spend a significant amount of time working to protect patients from acquiring infections while they are being cared for in the hospital.
September 19, 2023
Findings showed colonization with toxigenic C. difficile was associated with a greater risk of CDI during hospitalization than cross-transmission.
September 16, 2023
Survey results showed patients with a history of live biotherapeutic product therapy preferred rectally administered treatment while patients who had not received live biotherapeutic product therapy would be willing to consider it.
September 14, 2023
Patients with CDI and COVID-19 faced a higher risk of mortality and had higher CCI scores, a longer length of stay, and greater total hospital costs than patients infected with COVID-19 but not CDI.
September 7, 2023
Patients with CDI treated with oral metronidazole experienced significantly more first-line drug changes compared to those on fidaxomicin, although there were no significant differences observed in the global or clinical cure rate between the two treatments.